deaths from glp-1 Estimating the lives that could be saved by expanded access to weight-loss drugs RGA GLP-1 Study: Weighing the

The thing is it's not just about WHAT ingredients you use

Eli Lilly is studying the pill in a longer study in people who are overweight or have obesity to see if the weight loss continues

Do not use if you or your family have a history of a type of thyroid cancer called MTC (medullary thyroid carcinoma) or MEN 2 (multiple endocrine neoplasia syndrome)

The injectable weight-loss drug Wegovy is the only medication currently approved for cardiovascular indications in patients with overweight or obesity and existing cardiovascular disease

It is a trusted option for patients seeking diabetes management with added weight reduction benefits

New patients can schedule a consultation to discuss candidacy, comfort options, risks, and aftercare before treatment